Capital Fund Management S.A. Takes $2.18 Million Position in Henry Schein, Inc. $HSIC

Key Points

• Capital Fund Management S.A. purchased 31,863 shares of Henry Schein, Inc. valued at approximately $2.18 million in the first quarter.
• Wall Street analysts have revised their target prices for Henry Schein, with estimates ranging from $70.00 to $77.00, and a consensus rating of "Hold."
• Henry Schein reported a quarterly earnings miss, with $1.10 earnings per share, falling short of estimates by $0.09, despite a year-over-year revenue increase.

Capital Fund Management S.A. purchased a new stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 31,863 shares of the company's stock, valued at approximately $2,182,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Investment Management Corp VA ADV bought a new position in shares of Henry Schein in the 4th quarter valued at $32,000. Rakuten Securities Inc. bought a new position in shares of Henry Schein in the 1st quarter valued at $34,000. Whittier Trust Co. increased its stake in shares of Henry Schein by 714.3% in the 1st quarter. Whittier Trust Co. now owns 798 shares of the company's stock valued at $55,000 after purchasing an additional 700 shares during the last quarter. UMB Bank n.a. increased its stake in shares of Henry Schein by 23.2% in the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock valued at $73,000 after purchasing an additional 201 shares during the last quarter. Finally, Allworth Financial LP increased its stake in shares of Henry Schein by 24.5% in the 1st quarter. Allworth Financial LP now owns 1,178 shares of the company's stock valued at $78,000 after purchasing an additional 232 shares during the last quarter. Institutional investors own 96.62% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on HSIC shares. Evercore ISI upgraded Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 price target on the stock in a research note on Tuesday. Barrington Research decreased their price target on Henry Schein from $86.00 to $78.00 and set an "outperform" rating on the stock in a research note on Wednesday, August 6th. Baird R W lowered Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. UBS Group reduced their price objective on Henry Schein from $75.00 to $70.00 and set a "neutral" rating on the stock in a research report on Wednesday, August 6th. Finally, Stifel Nicolaus restated a "hold" rating and set a $75.00 price objective (down previously from $80.00) on shares of Henry Schein in a research report on Friday, July 25th. Five investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat.com, Henry Schein has an average rating of "Hold" and a consensus price target of $76.67.

Henry Schein Trading Up 0.3%

HSIC traded up $0.21 during midday trading on Friday, hitting $69.24. 495,248 shares of the company were exchanged, compared to its average volume of 1,760,794. The firm has a market capitalization of $8.40 billion, a P/E ratio of 22.34, a P/E/G ratio of 2.27 and a beta of 0.81. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49. The firm's 50 day moving average price is $70.40 and its 200-day moving average price is $70.14. The company has a quick ratio of 0.78, a current ratio of 1.41 and a debt-to-equity ratio of 0.51.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). The company had revenue of $3.24 billion for the quarter, compared to analyst estimates of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The firm's quarterly revenue was up 3.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.23 earnings per share. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, equities analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.